Commerzbank Aktiengesellschaft’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $833K | Sell |
13,733
-724
| -5% | -$42.2K | 0.02% | 221 |
|
|
2025
Q4 | $780K | Hold |
14,457
| – | – | 0.02% | 244 |
|
|
2025
Q3 | $653K | Sell |
14,457
-12,620
| -47% | -$589K | 0.01% | 239 |
|
|
2025
Q2 | $1.25M | Buy |
27,077
+13,551
| +100% | +$665K | 0.03% | 167 |
|
|
2025
Q1 | $825K | Hold |
13,526
| – | – | 0.02% | 196 |
|
|
2024
Q4 | $759K | Buy |
13,526
+3,639
| +37% | +$203K | 0.02% | 177 |
|
|
2024
Q3 | $512K | Buy |
9,887
+3,274
| +50% | +$154K | 0.01% | 194 |
|
|
2024
Q2 | $275K | Buy |
6,613
+551
| +9% | +$24.7K | 0.01% | 207 |
|
|
2024
Q1 | $329K | Buy |
+6,062
| New | +$309K | 0.01% | 193 |
|
|
2020
Q2 | – | Sell |
-48,653
| Closed | -$2.71M | – | 146 |
|
|
2020
Q1 | $2.71M | Sell |
48,653
-708,875
| -94% | -$43.3M | 0.12% | 96 |
|
|
2019
Q4 | $48.6M | Sell |
757,528
-123,764
| -14% | -$7.09M | 0.47% | 38 |
|
|
2019
Q3 | $44.7M | Buy |
881,292
+141,661
| +19% | +$6.66M | 0.34% | 61 |
|
|
2019
Q2 | $33.5M | Buy |
739,631
+149,312
| +25% | +$6.95M | 0.27% | 77 |
|
|
2019
Q1 | $28.2M | Buy |
590,319
+46,620
| +9% | +$2.32M | 0.26% | 83 |
|
|
2018
Q4 | $28.3M | Buy |
543,699
+31,932
| +6% | +$1.72M | 0.29% | 67 |
|
|
2018
Q3 | $31.8M | Sell |
511,767
-73,011
| -12% | -$4.33M | 0.28% | 75 |
|
|
2018
Q2 | $32.4M | Buy |
584,778
+62,006
| +12% | +$3.35M | 0.31% | 70 |
|
|
2018
Q1 | $33.1M | Sell |
522,772
-19,084
| -4% | -$1.23M | 0.34% | 65 |
|
|
2017
Q4 | $33.2M | Sell |
541,856
-7,701
| -1% | -$482K | 0.38% | 58 |
|
|
2017
Q3 | $35M | Buy |
549,557
+188
| +0% | +$11K | 0.46% | 45 |
|
|
2017
Q2 | $30.6M | Buy |
549,369
+89,383
| +19% | +$4.86M | 0.51% | 44 |
|
|
2017
Q1 | $25M | Buy |
459,986
+194,409
| +73% | +$10.7M | 0.37% | 62 |
|
|
2016
Q4 | $15.5M | Buy |
265,577
+128,959
| +94% | +$7.05M | 0.23% | 98 |
|
|
2016
Q3 | $7.37M | Buy |
136,618
+72,611
| +113% | +$4.66M | 0.12% | 157 |
|
|
2016
Q2 | $4.71K | Buy |
64,007
+10,333
| +19% | +$730K | 0.03% | 239 |
|
|
2016
Q1 | $3.43M | Sell |
53,674
-201,861
| -79% | -$12.7M | 0.03% | 291 |
|
|
2015
Q4 | $17.6M | Buy |
255,535
+199,719
| +358% | +$13.2M | 0.14% | 129 |
|
|
2015
Q3 | $3.3M | Sell |
55,816
-126,012
| -69% | -$7.99M | 0.02% | 362 |
|
|
2015
Q2 | $12.1M | Sell |
181,828
-34,878
| -16% | -$2.3M | 0.06% | 189 |
|
|
2015
Q1 | $14M | Sell |
216,706
-136,649
| -39% | -$8.55M | 0.08% | 173 |
|
|
2014
Q4 | $20.9M | Sell |
353,355
-286,044
| -45% | -$16.1M | 0.13% | 131 |
|
|
2014
Q3 | $32.7M | Buy |
639,399
+37,404
| +6% | +$1.87M | 0.13% | 121 |
|
|
2014
Q2 | $29.2M | Buy |
601,995
+151,793
| +34% | +$7.48M | 0.15% | 118 |
|
|
2014
Q1 | $23.4M | Sell |
450,202
-174,808
| -28% | -$9.3M | 0.1% | 134 |
|
|
2013
Q4 | $31.2M | Sell |
625,010
-128,862
| -17% | -$6.56M | 0.15% | 97 |
|
|
2013
Q3 | $34.9M | Sell |
753,872
-155,636
| -17% | -$6.83M | 0.17% | 109 |
|
|
2013
Q2 | $40.6M | Buy |
+909,508
| New | +$39.5M | 0.18% | 98 |
|
Other funds holding BMY
VCM
VPM
Commerzbank Aktiengesellschaft's BMY Position: Q1 2026 in Review
Commerzbank Aktiengesellschaft reduced its Bristol-Myers Squibb (BMY) stake by 5% in Q1 2026, selling an estimated $42.2K and leaving 13,733 shares worth $833K. The position accounts for 0.02% of the portfolio, ranked #221.
Commerzbank Aktiengesellschaft first reported a position in BMY in Q2 2013 and has held it in 37 quarters since. The position peaked at $48.6M in Q4 2019. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Commerzbank Aktiengesellschaft held 13,733 shares of Bristol-Myers Squibb worth $833K as of Q1 2026.
- Commerzbank Aktiengesellschaft sold 724 Bristol-Myers Squibb shares in Q1 2026, an estimated $42.2K.
- Bristol-Myers Squibb made up 0.02% of Commerzbank Aktiengesellschaft's portfolio in Q1 2026, its #221 holding.
- Commerzbank Aktiengesellschaft first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 37 quarters since.
- Commerzbank Aktiengesellschaft's Bristol-Myers Squibb position peaked at $48.6M in Q4 2019.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2026, filed 7 May 2026.